Insiders · OBIO

OBIO insider transactions

Orchestra BioMed Holdings Inc. (OBIO) Form 4 insider transactions - real-time wire coverage of every officer, director, and 10% owner trade.

Recent Form 3, 4, and 5 filings for OBIO

• 2d
  Large owner Rtw Investments, Lp exercised 1,250,032 in-the-money shares at a strike of $0.00 and sold $132 worth of shares (32 units at $4.13) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 35d
  SEC Form 4 filed by Hochman David P

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 46d
  Officer Hochman David P bought $42,900 worth of shares (10,000 units at $4.29), increasing direct ownership by 0.93% to 1,086,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  SEC Form 4 filed by Principal Accounting Officer Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Officer Sherman Darren was granted 397,000 shares, increasing direct ownership by 47% to 1,237,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Chief Financial Officer Taylor Andrew Lawrence was granted 181,000 shares, increasing direct ownership by 40% to 632,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 77d
  Officer Hochman David P was granted 504,000 shares, increasing direct ownership by 88% to 1,076,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 84d
  Director Cleary Chris covered exercise/tax liability with 676 shares, decreasing direct ownership by 2% to 36,901 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 84d
  SEC Form 4 filed by Officer Sherman Darren

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,452 shares, decreasing direct ownership by 0.76% to 451,493 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 241 shares, decreasing direct ownership by 1% to 18,885 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 119d
  Officer Sherman Darren covered exercise/tax liability with 5,588 shares, decreasing direct ownership by 0.66% to 840,569 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 140d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 8,670 shares, decreasing direct ownership by 2% to 454,945 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 140d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 7% to 572,467 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 156d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 3,071 shares, decreasing direct ownership by 0.66% to 463,615 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 156d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 5% to 846,157 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 165d
  Officer Hochman David P bought $20,350 worth of shares (5,000 units at $4.07), increasing direct ownership by 0.82% to 612,822 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 168d
  Officer Hochman David P covered exercise/tax liability with 6,566 shares, decreasing direct ownership by 0.54% to 607,822 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Director Aryeh Jason bought $2,450 worth of shares (1,000 units at $2.45), increasing direct ownership by 0.93% to 108,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 203 shares, decreasing direct ownership by 1% to 19,126 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 16,102 shares, decreasing direct ownership by 3% to 466,686 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 224d
  Officer Hochman David P covered exercise/tax liability with 43,638 shares, decreasing direct ownership by 6% to 611,105 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 238d
  Officer Sherman Darren covered exercise/tax liability with 40,340 shares, decreasing direct ownership by 4% to 886,497 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 249d
  Director Fain Eric S bought $15,034 worth of shares (5,760 units at $2.61) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 249d
  Officer Sherman Darren bought $7,860 worth of shares (3,000 units at $2.62), increasing direct ownership by 0.32% to 926,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 249d
  Officer Hochman David P bought $14,940 worth of shares (6,000 units at $2.49), increasing direct ownership by 0.93% to 651,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 249d
  Chief Financial Officer Taylor Andrew Lawrence bought $5,100 worth of shares (2,000 units at $2.55), increasing direct ownership by 0.42% to 482,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Chief Financial Officer Taylor Andrew Lawrence was granted 80,000 shares, increasing direct ownership by 20% to 480,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Aryeh Jason was granted 15,000 shares, increasing direct ownership by 16% to 107,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Officer Sherman Darren was granted 120,000 shares, increasing direct ownership by 15% to 923,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Connealy Pamela Ann was granted 15,000 shares, increasing direct ownership by 44% to 48,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Mack John Prosper was granted 15,000 shares, increasing direct ownership by 59% to 40,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Fain Eric S was granted 15,000 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Cleary Chris was granted 15,000 shares, increasing direct ownership by 66% to 37,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Officer Hochman David P was granted 200,000 shares, increasing direct ownership by 18% to 645,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Director Pacitti David was granted 15,000 shares, increasing direct ownership by 50% to 44,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 266d
  Principal Accounting Officer Aiello Joshua was granted 15,000 shares, increasing direct ownership by 347% to 19,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 268d
  SEC Form 4 filed by Large owner Rtw Investments, Lp

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 269d
  Large owner Perceptive Advisors Llc bought $1,925,000 worth of shares (700,000 units at $2.75) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 270d
  Officer Hochman David P bought $55,000 worth of shares (20,000 units at $2.75) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 308d
  Director Fain Eric S sold $8,183 worth of shares (2,683 units at $3.05) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 308d
  Director Aryeh Jason was granted 12,422 shares, increasing direct ownership by 16% to 92,482 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Cleary Chris was granted 12,422 shares, increasing direct ownership by 122% to 22,577 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Mack John Prosper was granted 12,422 shares, increasing direct ownership by 97% to 25,286 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Connealy Pamela Ann was granted 12,422 shares, increasing direct ownership by 58% to 33,711 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Fain Eric S was granted 12,422 shares (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 309d
  Director Pacitti David was granted 12,422 shares, increasing direct ownership by 71% to 29,968 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 315d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 393 shares, decreasing direct ownership by 8% to 4,329 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 322d
  Chief Financial Officer Taylor Andrew Lawrence covered exercise/tax liability with 28,172 shares, decreasing direct ownership by 7% to 400,788 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 322d
  Officer Hochman David P covered exercise/tax liability with 39,709 shares, decreasing direct ownership by 6% to 545,460 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 336d
  Officer Sherman Darren covered exercise/tax liability with 45,843 shares, decreasing direct ownership by 5% to 803,837 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 365d
  Large owner Rtw Investments, Lp bought $149,201 worth of shares (49,900 units at $2.99) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 367d
  Large owner Rtw Investments, Lp bought $126,500 worth of shares (50,000 units at $2.53) (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Officer Hochman David P was granted 98,333 shares, increasing direct ownership by 20% to 579,498 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  SEC Form 4 filed by Principal Accounting Officer Aiello Joshua

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Officer Sherman Darren was granted 115,708 shares, increasing direct ownership by 16% to 849,680 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 392d
  Chief Financial Officer Taylor Andrew Lawrence was granted 84,000 shares, increasing direct ownership by 24% to 428,960 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)
• 399d
  Principal Accounting Officer Aiello Joshua covered exercise/tax liability with 278 shares, decreasing direct ownership by 6% to 4,722 units (SEC Form 4)

  4 - Orchestra BioMed Holdings, Inc. (0001814114) (Issuer)